Search Within

Solid Tumor Oncology Division

Formats
  1. Journal Article (10926)
  2. Meeting Abstract (9499)
  3. Review (556)
  4. Book Section (417)
  5. Editorial (336)
  6. Guidelines (157)
  7. Correspondence (118)
  8. Conference Paper (107)
  9. Research Letter (61)
  10. Miscellaneous (54)
  11. Book Whole (27)
Groups
  1. Department of Medicine (22235)
  2. GSK Faculty (5929)
  3. Genitourinary Oncology Service (5648)
  4. Survivorship Research (5226)
  5. Gastrointestinal Oncology Service (4689)
  6. Breast Medicine Service (4155)

More Groups

People
  1. Robert Motzer (1247)
  2. Howard Scher (1130)
  3. Clifford Hudis (905)
  4. Jedd Wolchok (905)
  5. Mark Kris (872)
  6. Leonard Saltz (792)

More People

Years
  1. 2025 (635)
  2. 2024 (1388)
  3. 2023 (1381)
  4. 2022 (1573)
  5. 2021 (1517)
  6. 2020 (1536)

More Years

Publications
  1. Journal of Clinical Oncology (5286)
  2. Annals of Oncology (1297)
  3. Cancer Research (1012)
  4. Clinical Cancer Research (776)
  5. Journal of Thoracic Oncology (532)
  6. Gynecologic Oncology (441)

More Publications

Publishers
  1. American Society of Clinical Oncology (5578)
  2. Elsevier Inc. (2661)
  3. American Association for Cancer Research (2327)
  4. Oxford University Press (1819)
  5. Nature Publishing Group (1043)
  6. Springer (981)

More Publishers

Results (22258)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Utilizing patient input in rectal cancer trial design
    Journal Article

    Alvarez, J.; Zambare, W.; George, M.; Garcia, R.; Gallagher, P.; Kitchens, C.; Bercz, A.; Kim, M. J.; Romesser, P. B.; Cercek, A.; more...
    JNCI: Journal of the National Cancer Institute (2025)

    Fulltext@MSK | Save
  • Symptomatic prostate-specific membrane antigen PET–positive radionecrosis after multimodality brain metastasis–directed treatment including [(177)Lu]Lu-PSMA-617
    Journal Article

    Imber, B. S.; Yu, K. K. H.; Abida, W.; Pike, L. R. G.; Grkovski, M.; Kaley, T. J.; Morris, M. J.; Bodei, L.; Nosov, A.; Dunphy, M. P. S.; more...
    Journal of Nuclear Medicine (2025)

    Fulltext@MSK | Save
  • Response to letter to the editor from Zhang et al: "Cabozantinib plus ipilimumab/nivolumab in patients with previously treated advanced differentiated thyroid cancer"
    Correspondence

    Konda, B.; Sherman, E. J.; Massarelli, E.; Nieva, J.; Muzaffar, J.; Morris, J. C. 3rd; Ryder, M.; Ho, A. L.; Agulnik, M.; Wei, L.; more...
    Journal of Clinical Endocrinology and Metabolism (2025)

    Fulltext@MSK | Save
  • A randomized controlled trial of the Integrated Cancer Care Access Network on cancer treatment completion and quality of life
    Journal Article

    Gany, F.; Melnic, I.; Li, Y.; Finik, J.; Wu, M.; Ramirez, J.; Hwang, C.; Leng, J.; Blinder, V.
    Journal of the National Comprehensive Cancer Network (2025)

    Fulltext@MSK | Save
  • Relationship among DNA damage response gene alterations, molecular subtypes, and survival outcomes in patients with metastatic bladder cancer treated on CALGB 90601
    Journal Article

    Iyer, G.; Choi, W.; Luo, B.; Carvalho, F.; Hanlon, T.; Reis, H.; Guercio, B. J.; Fong, M.; Mountain, J.; Feng, M.; more...
    JCO Precision Oncology (2025)

    Fulltext@MSK | Save
  • Utilizing Immuno-Oncology registry data for enhanced non-small cell lung cancer treatment predictions
    Journal Article

    Zhang, Y.; Lev-Ari, S.; Zaemes, J.; Pia, A. D.; DeAgresta, B.; Gupta, S.; Marki, A.; Zemel, R.; Ip, A.; Alaoui, A.; more...
    JAMIA Open (2025)

    Fulltext@MSK | Save
  • Oral mucositis associated with antibody-drug conjugates in gynecologic oncology: Strategies for prevention and treatment
    Review

    Lightfoot, M. D. S.; Rubinstein, M. M.; Monk, B. J.; Eskander, R. N.; Lutz, K.; Moore, K. N.; Herzog, T. J.; Pothuri, B.
    International Journal of Gynecological Cancer (2025)

    Fulltext@MSK | Save
  • A plain language summary of two trials for larotrectinib in people with TRK fusion-positive lung cancer to learn how well the drug works and how safe it is
    Journal Article

    Drilon, A.; Lin, J. J.; Burcoveanu, D. I.; Ollis, C.; Reiss, M.; Torberger, O.; Moreno, V.
    Future Oncology (2025)

    Fulltext@MSK | Save
  • A phase I study of the CSF1R inhibitor vimseltinib in combination with the PD-L1 inhibitor avelumab in patients with advanced sarcoma
    Journal Article

    Rosenbaum, E.; Seier, K.; Bradic, M.; Movva, S.; Kelly, C. M.; Dickson, M. A.; Keohan, M. L.; Gounder, M. M.; Chi, P.; Nacev, B. A.; more...
    ESMO Open (2025)

    Fulltext@MSK | Save
  • Rucaparib for maintenance treatment of platinum-sensitive, recurrent ovarian carcinoma: Final results of the phase 3, randomized, placebo-controlled ARIEL3 trial
    Journal Article

    Ledermann, J. A.; Oza, A. M.; Lorusso, D.; Aghajanian, C.; Oaknin, A.; Dean, A.; Colombo, N.; Weberpals, J. I.; Clamp, A. R.; Scambia, G.; more...
    European Journal of Cancer (2025)

    Fulltext@MSK | Save